Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
frrol, it is interesting to note that many of the WTG crowd here at Anavex were giving Cassava low marks from the beginning.
Maybe, they know MORE than you and your "Rikker-friends".
Thanks, T.
22%? Relative to "When"? April?
Bourbon, sounds great and always like your posts.
Peace
powerwalker
So, Bourbon, are you the trigger guy for when to buy? $6.20 w/ 210K traded @ 10:37.
Yes, the error was that george did not explain the "*", which is:
... and it goes BOTH WAYS!!
FYI re: likes - From earlier today:
Fully agree, Hoskuld, and to state it another way ...
Data should be released by end of October, which is Rett month
Here's an example ... at 9:14 PM 10/5, this post had 8 likes but only 3 show on the "front page" of the Anavex MB.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172967422
This is in addition to the likes on the post that don't even make it to the "front page."
Add this one from Mayo: no likes on front page, but 12 on post.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172959674
Why can't iHub get the "thumbs up" icon correct between the post and the summary? Also, with the correct number!
I'm OK now!
nidan, I'm receiving a "Block" message to iHub if I use the "Next" or "Prev" arrows. Not an issue if I use the mouse's previous button.
Is it an issue within iHub?
Receive a request from Fidelity to lend out my Anavex shares. The interest rate ... a paltry .375 of 1%!!
I obviously said "No" as I have done, even when the rate was in double digits.
Our discussion was geared towards the results of the P2a trial and not pre-clinical tests.
Your rush to always chastise the pro-Anavex crowd shows your own ignorance and lack of objectivity.
bas, Anavex will show superb Excellence results and should compare those numbers to the ACAD results, which will be glaring as to how poor its drug compares to blarcamesine.
Given that and the nastiness of this disease, AF would be hard pressed to viciously attack the results of 2-73 as the backlash against him might be staggering if the Mothers of the Rett girls get their dander up ... he might try but it will backfire on him, IMO. He should save his credibility for the AD fight.
But why didn't Anavex 2-73 Plus work? That combo was 2-73 + DPZ and wasn't used to replace the Aricept and similar in the trial for the 67% on it ... or is it in the bullpen waiting to be called in?
P.S. Go O's!!!
Now, he has taken HGEN under, for all practical purposes.
Correction, Investor, "Strong", not Super.
Plus, we are still waiting for the sub-group details from P2b/3 trial.
FBAG, join the APT study and you may get the test for free.
Here is the link to the APT Webstudy: app.aptwebstudy.org
I took it two plus weeks ago and should receive results by end of October.
plex, Ionis' efforts are preclinical and it's only $60 million for two drugs now:
Roche's bet is not much, given the timeline of 10+ years before any consideration for approval.
Actually, Ziggy, in the P2a trial, there were six participants, a/k/a "Strong Responders," whose MMSE score increased thru Week 57, and five of those thru Week 109. These were the only ones who improved in that trial and each was DPZ-naive.
MMSE Scores by Week
SR 0 31 57 Inc (Dec) 109 Inc (Dec)
1009 20 24 26 6 29 9
1011 20 23 22 2 21 1
1014 20 22 25 5 25 5
2006 25 28 29 4 28 3
2010 25 28 28 3 28 3
1013* 22 24 24 2 18 -4
22 17
Average 3.7 2.8
Average w/o 1013 4.0 4.2
* Significant decline from Week 57 (24) to Week 70 (18)
As to the P2b/3 trial, only Anavex knows if there were any Strong Responders and, if so, how many, though indications from data presented are that there are some.
P.S. Sorry, Ziggy, as the chart does not line-up properly, so you'll have to use your imagination in structuring the columns.
Thanks, hnbadger, for the article. I wish, however, the word structure to this would use "minimize brain reduction" rather than:
Your handler, Rikker 19, gave you a "pat on the back" with its thumb up.
I think, if available, you would earn a score plus of "thumbs down."
Especially, one down from me!
Moon, isn't there a Rett Conference in the middle of the month? It was noted here awhile back, but I haven't been able to find it.
TIA if anyone else is able.
george, this is the newest member of the SAB, Prof. Dr. Marwan N Sabbagh, MD, as Chairman of the Scientific Advisory Board.
https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/92019755/anavex-announces-appointment-of-dr-marwan-n-sabba
Here is the web site to help your spelling... and other issues you have.
https://www.anavex.com/
How, ath, would we know something? By what Anavex tells us, i.e., it achieved the endpoints in P2b/3 trial as noted in 12/22 PR and it has sufficient results to proceed with AA soon, noted in last week's PR. Not to mention, the indications that the peds' Rett trial will demonstrate efficacy with those young girls.
We know that, right ... now, all we need to do is wait for the Rett numbers and the expectant peer review paper on AD trial data.
Will one of the mods "stick" this?
Actually summarizes the two camps: No one knows "jack" when compared to what Anavex and TGD knows!
TIA
So ...
bas, raja nor anyone else would have known about "super responders" because Dr. Missling never called them that ... he called them "Strong Responders." TGD did not want the word "super" used due to its misinterpretation as to the results.
Only on MB's, is "super" used.
Still, unbelievable given the extent of content and your interpretation, writing and posting in 108 seconds.
P.S. Investor, saw your post re: tweet. That explains it!
So, Investor, do you get an advance notice of Anavex's PR? The PR was released at 7:29 AM, EDT, and your lengthy post was printed on 7:30:48, less than two minutes thereafter.
???
X, I am, too, but the Hopkins doctors claim his liver is shot and now their concern is help his kidneys to make him comfortable for his last few weeks. Also, dialysis is not happening.
Heard you have been on an upward trajectory. Glad to know.
Thanks, Hoskuld and Investor, for your concerns/empathy.
Believe what you want.
FYI - I'm off to daily Mass, but this time to pray for a family member with only weeks left as he suffers from an aggressive form of liver cancer, which was only discovered in late July.
My guess is that he has seen mucho more data than anyone on this MB has, including you and Doc.
His inclusion, Kb, is to increase credibility in those numbers as an expert in the field and one who will be able to speak the truth to others when the time comes. He is not there for more blarcamesine AD P3 trials as you insinuate.
Investor, I wouldn't call it nothing. As an authority in the field, he has seen the data, calls it "... robust clinical data ..." and, then, says "Yes!" to joining the SAB as its chairman. If he did not think it were good, he would not have signed-up.
mike, only if you and your handlers want it to go there!